Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Brazilian (BOVESPA) Healthcare Sector Analysis

UpdatedJan 12, 2026
DataAggregated Company Financials
Companies16
  • 7D1.6%
  • 3M-1.2%
  • 1Y30.6%
  • YTD1.2%

The Healthcare industry is up 1.6% in the last week, with Rede D'Or São Luiz up 0.6%. This takes the industry's 12 month performance to a gain of 31%. As for the next few years, earnings are expected to grow by 26% per annum.

Sector Valuation and Performance

Has the Brazilian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 12 Jan 2026R$145.3bR$152.1bR$1.8b12.3x78.7x1x
Wed, 10 Dec 2025R$148.6bR$152.1bR$1.8b12x80.5x1x
Fri, 07 Nov 2025R$155.2bR$151.9bR$2.9b11x53.6x1x
Sun, 05 Oct 2025R$153.4bR$149.9bR$2.5b11.6x61.4x1x
Tue, 02 Sep 2025R$150.0bR$149.9bR$2.5b12.1x60.1x1x
Thu, 31 Jul 2025R$133.2bR$149.5bR$2.0b11.6x65.3x0.9x
Sat, 28 Jun 2025R$139.0bR$149.5bR$2.0b11.1x68.2x0.9x
Mon, 26 May 2025R$146.0bR$149.6bR$2.0b10.6x71.6x1x
Wed, 23 Apr 2025R$122.4bR$148.5bR$2.4b10.2x51.2x0.8x
Fri, 21 Mar 2025R$120.9bR$150.6bR$5.8b11x20.8x0.8x
Sun, 16 Feb 2025R$122.6bR$146.7bR$4.7b11.6x26.3x0.8x
Tue, 14 Jan 2025R$110.7bR$146.7bR$4.7b10.7x23.7x0.8x
Thu, 12 Dec 2024R$119.7bR$146.7bR$4.7b12.2x25.7x0.8x
Sat, 09 Nov 2024R$133.7bR$144.6bR$4.5b12x29.9x0.9x
Mon, 07 Oct 2024R$145.9bR$144.9bR$4.4b11x33.1x1x
Wed, 04 Sep 2024R$155.4bR$144.9bR$4.4b11.8x35.3x1.1x
Fri, 02 Aug 2024R$142.0bR$143.3bR$4.2b11.3x34.2x1x
Sun, 30 Jun 2024R$137.9bR$142.9bR$4.2b11.4x33x1x
Tue, 28 May 2024R$148.3bR$142.9bR$4.2b11.6x35.5x1x
Thu, 25 Apr 2024R$132.6bR$140.0bR$3.2b11.7x41.8x0.9x
Sat, 23 Mar 2024R$148.0bR$133.3bR$2.6b13.7x57.6x1.1x
Mon, 19 Feb 2024R$145.3bR$132.9bR$2.7b15.7x53.6x1.1x
Wed, 17 Jan 2024R$166.5bR$135.0bR$2.9b19.4x57.8x1.2x
Fri, 15 Dec 2023R$169.2bR$135.0bR$2.9b20.9x58.7x1.3x
Sun, 12 Nov 2023R$154.8bR$133.8bR$2.7b22.3x57.2x1.2x
Tue, 10 Oct 2023R$154.8bR$126.1bR$2.7b18.5x56.3x1.2x
Thu, 07 Sep 2023R$170.5bR$126.1bR$2.7b19.6x62x1.4x
Sat, 05 Aug 2023R$196.6bR$117.6bR$2.9b16.2x68.5x1.7x
Mon, 03 Jul 2023R$186.8bR$116.7bR$2.8b17.2x66.3x1.6x
Wed, 31 May 2023R$166.9bR$110.8bR$2.8b15.3x60.6x1.5x
Fri, 28 Apr 2023R$130.7bR$106.3bR$3.3b14.7x39.3x1.2x
Sun, 26 Mar 2023R$127.9bR$104.5bR$3.7b14x34.4x1.2x
Tue, 21 Feb 2023R$176.2bR$98.8bR$4.2b16.2x41.6x1.8x
Thu, 19 Jan 2023R$164.4bR$98.3bR$4.2b15.4x39.5x1.7x
Price to Earnings Ratio

39.5x


Total Market Cap: R$164.4bTotal Earnings: R$4.2bTotal Revenue: R$98.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Healthcare Sector Price to Earnings3Y Average 49.2x202420252026
Current Industry PE
  • Investors are optimistic on the Brazilian Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 78.7x which is higher than its 3-year average PE of 49.2x.
  • The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.96x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 24% per year over the last three years.
  • Meanwhile revenues for these companies have grown 16% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Brazilian Healthcare sector?

BR Market0.78%
Healthcare1.56%
Medical Equipment6.44%
Healthcare Services1.73%
Pharma0.98%
Biotech-2.10%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 110x.
    • Analysts are expecting annual earnings growth of 26.6%, which is higher than its past year's earnings growth of 7.1% per year.
  • Investors are most pessimistic about the Medical Equipment industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 0.79x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 27% over the next 5 years.
  • This is better than its past earnings growth rate of 7.1% per year.
  • In contrast, the Biotech industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RDOR3 Rede D'Or São LuizR$41.190.6%
+R$529.6m		58.1%PE20.5x
HAPV3 Hapvida Participações e InvestimentosR$15.254.7%
+R$341.6m		-53.8%PS0.2x
FLRY3 FleuryR$15.503.3%
+R$272.5m		34.2%PE14.1x
DASA3 Diagnósticos da AméricaR$3.983.9%
+R$187.5m		116.3%PS0.4x
HYPE3 HyperaR$23.560.4%
+R$63.3m		31.0%PE18.1x

Latest News

RDOR3
R$41.19
Rede D'Or São Luiz
7D
0.6%
1Y
58.1%

Is It Too Late To Consider Buying Rede D'Or São Luiz S.A. (BVMF:RDOR3)?

Jan 11
Is It Too Late To Consider Buying Rede D'Or São Luiz S.A. (BVMF:RDOR3)?
ONCO3
R$2.74
Oncoclínicas do Brasil Serviços Médicos
7D
0.7%
1Y
31.7%
QUAL3
R$2.21
Qualicorp Consultoria e Corretora de Seguros
7D
-2.6%
1Y
50.3%
DASA3
R$3.98
Diagnósticos da América
7D
3.9%
1Y
116.3%
BLAU3
R$10.41
Blau Farmacêutica
7D
-7.2%
1Y
6.1%
HAPV3
R$15.25
Hapvida Participações e Investimentos
7D
4.7%
1Y
-53.8%

HAPV3: Index Reclassification And Earnings Multiple Will Support Future Upside

Analysts have trimmed their price target on Hapvida Participações e Investimentos to R$18.50 from R$21.00, citing revised fair value assumptions that include adjustments to discount rates, revenue growth expectations, profit margins and future P/E estimates. What's in the News Hapvida Participações e Investimentos S.A. was added to the Brazil Small Cap Index, reflecting its current classification within Brazilian equity indices (Key Developments).
VVEO3
R$1.37
CM Hospitalar S/A
7D
3.8%
1Y
-27.5%
FLRY3
R$15.50
Fleury
7D
3.3%
1Y
34.2%

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Jan 07
Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?
HYPE3
R$23.56
Hypera
7D
0.4%
1Y
31.0%

HYPE3: Future P/E Multiple Expansion Will Support Further Upside Potential

Analysts have slightly increased their price target on Hypera to reflect updated fair value estimates and adjustments to revenue growth, profit margin expectations, and future P/E assumptions. What's in the News Hypera S.A. is scheduled to hold a board meeting on Dec 11, 2025, which may address governance, capital allocation, or operational planning (company event filing).
BIOM3
R$7.06
Biomm
7D
-5.9%
1Y
-23.8%

Lacklustre Performance Is Driving Biomm S.A.'s (BVMF:BIOM3) 25% Price Drop

Jan 04
Lacklustre Performance Is Driving Biomm S.A.'s (BVMF:BIOM3) 25% Price Drop
PFRM3
R$8.21
Profarma Distribuidora de Produtos Farmacêuticos
7D
-4.5%
1Y
34.6%
ODPV3
R$11.19
Odontoprev
7D
-3.8%
1Y
6.0%

Some Confidence Is Lacking In Odontoprev S.A.'s (BVMF:ODPV3) P/E

Dec 19
Some Confidence Is Lacking In Odontoprev S.A.'s (BVMF:ODPV3) P/E
MATD3
R$5.27
Hospital Mater Dei
7D
2.3%
1Y
44.4%
AALR3
R$4.46
Alliança Saúde e Participações
7D
-5.1%
1Y
-54.0%